Literature DB >> 14516651

Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET.

Seok ki Kim1, June Key Chung, Byung Tae Kim, Sun Jung Kim, Jae Min Jeong, Dong Soo Lee, Myung Chul Lee.   

Abstract

The pattern and intensity of F-18-FDG uptake in the gastrointestinal (GI) tract are variable and can often cause confusion. The purpose of this study was to evaluate the relationship between GI tract symptoms and GI uptake of F-18-FDG. We evaluated whole-body FDG-PET of 314 persons (M:F = 147:167; 13-83 years) in whom pathologic GI tract disorders had not been observed. Uptake score and pattern were evaluated visually. Symptoms were grouped as follows: diarrhea, constipation, and neither diarrhea nor constipation. Among symptom groups, there was no statistically significant difference in FDG uptake score. But intense FDG uptake with focal pattern, which can cause confusion, was observed more frequently in the descending colon of patients with constipation than in those with diarrhea or without GI symptoms. When focal intense FDG uptake is observed in the abdomino-pelvic area, stricter attention to GI symptoms would improve the specificity of whole-body FDG-PET.

Entities:  

Year:  1999        PMID: 14516651     DOI: 10.1016/s1095-0397(99)00030-8

Source DB:  PubMed          Journal:  Clin Positron Imaging        ISSN: 1095-0397


  21 in total

1.  Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis.

Authors:  Robert Murphy; Kirk M Doerger; Mark A Nathan; Val J Lowe
Journal:  Mol Imaging Biol       Date:  2008-11-27       Impact factor: 3.488

2.  Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings.

Authors:  Julian Kirchner; Benedikt M Schaarschmidt; Firas Kour; Lino M Sawicki; Ole Martin; Johannes Bode; Stephan Vom Dahl; Verena Keitel; Dieter Häussinger; Christina Antke; Christian Buchbender; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-07       Impact factor: 9.236

3.  Early colon cancer detected by 18F-FDG PET.

Authors:  Kazuhiro Sakamoto; Makoto Takahashi; Yukihiro Yaginuma; Yasunori Ishido; Takashi Matsuoka; Shuichi Sakamoto; Yuichi Tomiki; Toshiki Kamano
Journal:  Int J Gastrointest Cancer       Date:  2005

4.  Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle.

Authors:  Seok-Ki Kim; Keon Wook Kang; Ju Won Roh; Jung Suk Sim; Eun Sook Lee; Sang-Yoon Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-17       Impact factor: 9.236

5.  Relationship Between Dual-Time Point FDG PET and Immunohistochemical Parameters in Preoperative Colorectal Cancer: Preliminary Study.

Authors:  Jai Hyuen Lee; Won Ae Lee; Seok Gun Park; Dong Kook Park; Hwan Namgung
Journal:  Nucl Med Mol Imaging       Date:  2012-01-03

6.  Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?

Authors:  F B van Hoeij; R G M Keijsers; B C A J Loffeld; G Dun; P H G M Stadhouders; B L A M Weusten
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-20       Impact factor: 9.236

7.  Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer.

Authors:  Seok-Ki Kim; Keon Wook Kang; Jong Seok Lee; Hark Kyun Kim; Hee Jin Chang; Jin Yi Choi; Jun Ho Lee; Keun Won Ryu; Young-Woo Kim; Jae-Moon Bae
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-15       Impact factor: 9.236

8.  Clinical significance of incidental colonic 18F-FDG uptake on PET/CT images in patients with gastric adenocarcinoma.

Authors:  Jung Ho Shim; Joo Hyun O; Seong Il Oh; Han Mo Yoo; Hae Myung Jeon; Cho Hyun Park; Sung Hoon Kim; Kyo Young Song
Journal:  J Gastrointest Surg       Date:  2012-06-30       Impact factor: 3.452

9.  High and typical 18F-FDG bowel uptake in patients treated with metformin.

Authors:  Eric Gontier; Emmanuelle Fourme; Myriam Wartski; Cyrille Blondet; Gerald Bonardel; Elise Le Stanc; Marina Mantzarides; Herve Foehrenbach; Alain-Paul Pecking; Jean-Louis Alberini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-05       Impact factor: 9.236

10.  Normal Physiologic and Benign Foci with F-18 FDG Avidity on PET/CT in Patients with Breast Cancer.

Authors:  Soon-Ah Park; Kwang-Man Lee; UnJong Choi; Hun Soo Kim; Hye-Won Kim; Jeong Hoon Song
Journal:  Nucl Med Mol Imaging       Date:  2010-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.